<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02501681</url>
  </required_header>
  <id_info>
    <org_study_id>Atadek 2014-723</org_study_id>
    <nct_id>NCT02501681</nct_id>
  </id_info>
  <brief_title>Evaluation of Different Priming Solutions Effects on Microcirculation, Oxidative Stress and Morbidity in Cardiovascular Surgery Patients</brief_title>
  <acronym>Acibadem</acronym>
  <official_title>Evaluation of Different Priming Solutions Effects on Microcirculation, Oxidative Stress and Morbidity in Cardiovascular Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Centre Leeuwarden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Centre Leeuwarden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-centre prospective randomized study will be included the patients who undergo elective
      cardiovascular surgery. Preoperative fluid deficit will be calculated by the formula as
      starvation period X 4 X weight. Patients will be divided into two groups: Group A (n=20);
      crystalloid as priming solution used in patients, Group B (n=20); colloids as priming
      solution used in patients. In addition to priming solutions, extracorporeal pump will be
      filled with 150 mL of Mannitol, 60 mL of NaHCO3 and 10000 IU Insulin. Standard anesthesia
      protocol will be administered to all patients. Ringer's Lactate will be given at first 30
      minute after induction. Ringer's Lactate as fluid maintenance will be administered at a rate
      of 100 mL/h except in extracorporeal circulation. Goal-directed fluid management will be
      performed by PVI (Pleth Variability Index). Cut off level of PVI will be accepted %15.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For integrative investigation of the effects of priming solution and postoperative fluid
      management on the complex interrelation between microcirculation and reactive oxygen species;
      sublingual microcirculation using microcirculation imaging system (IDF, Cytocam, NL) will be
      displayed and measure ekstra vascular lung water (EVLW) using PiCCO and plasma levels of
      oxidative stress markers will be measured. Sublingual tissue microcirculation will be
      evaluated in all patients at different time points as before induction (T0), after induction
      (T1), before cross clamping-hypothermic period (T2), after cross clamping (T3), before end of
      pump (normothermic period, heating) (T4), acceptance to intensive care unit (T5), third hour
      after surgery (T6) and twenty forth hour after surgery (T7).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in microvascular flow index (MFI)</measure>
    <time_frame>1 day</time_frame>
    <description>hemodilution by the priming solutions in extracorporeal circulation affects the sublingual microcirculation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference in MFI</measure>
    <time_frame>1 day</time_frame>
    <description>differences can be detected in the microcirculatory response to crystaloid priming in relation to colloid (starch) priming.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Microcirculation</condition>
  <arm_group>
    <arm_group_label>crystalloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A (n=20); crystalloid as priming solution used in patients,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>colloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B (n=20); colloids as priming solution used in patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>priming solution during cardiovascular surgery</intervention_name>
    <arm_group_label>crystalloid</arm_group_label>
    <arm_group_label>colloid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cardiovascular surgery needed

        Exclusion Criteria:

          -  no informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical Centre Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8901 BR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2015</study_first_submitted>
  <study_first_submitted_qc>July 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2015</study_first_posted>
  <last_update_submitted>August 18, 2015</last_update_submitted>
  <last_update_submitted_qc>August 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Centre Leeuwarden</investigator_affiliation>
    <investigator_full_name>Matty Koopmans</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <keyword>sublingual microcirculation</keyword>
  <keyword>cardiovascular surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

